What is the translation of " KRAJU ISPITIVANJA " in English?

• end of the study
• the end of the trial
• end of the studies
• the end of the examination

Examples of using Kraju ispitivanja in Croatian and their translations into English

Vrlo rijetko: jedan slučaj ireverzibilne alopecije na kraju ispitivanja.
Very rare: one case of alopecia non-reversible at the end of the study.

Na kraju ispitivanja nije bilo problema vezanih uz projekt.
At the end of the examination, there were no problems related to the project.

Postotak bolesnika sa stabiliziranim razinama hemoglobina na kraju ispitivanja.
Percentage of patients with stabilized Haemoglobin levels at end of study.

Na kraju ispitivanja konstatirano je da nema problema vezanih uz projekt.
At the end of the examination, there were no problems related to the project.

Srednja doza inzulina glargina jačine 100 jedinica/ml na kraju ispitivanja bila je 0, 42 jedinice/kg.
Mean dose of insulin glargine 100 units/ml by study end was 0.42 U/kg.

Na kraju ispitivanja, 43,6%(skupina s primjenom uz glavni obrok) i 42,8%(skupina s primjenom uz doručak) bolesnika postiglo je vrijednost HbA1c manju od 7.
At the end of the study, 43.6%(main meal group) and 42.8%(breakfast group) of patients achieved an HbA1c less than 7.

Yohimbin praškasta skupina imala je značajno bolju težinu na kraju ispitivanja.
The yohimbine powder group had a significantly better weight reduction at the end of the trial.

Na kraju ispitivanja 3(50%), 2(33%) i 2(33%) ispitanika postiglo je smanjenje od 1 dana, 2 dana odnosno 3 dana tjedno na parenteralnoj prehrani.
At the end of study, 3(50%), 2(33%) and 2(33%) achieved a reduction of 1, 2, or 3 days per week in parenteral nutrition, respectively.

Nije bilo abnormalnih nalaza palpacije dojki u skupini koja je primala placebo na početku ili na kraju ispitivanja.
There were no abnormal breast palpation findings in the placebo group at baseline or at study end.

Morali su gledati jedno drugom u oči Zvuči suludo. Na kraju ispitivanja četiri minute bez ijedne riječi.
They had to stare into each other's eyes Sounds ridiculous. At the end of the study, for four minutes without saying a word.

Nadalje, bolesnici koji su liječeni Glyberom u kliničkom ispitivanju bit će uključeni u registar na kraju ispitivanja.
In addition, patients, who have been treated with Glybera in a clinical trial shall be enrolled in the registry at the end of the trial.

Na kraju ispitivanja, ispitanici uključeni u dva ispitivanja III faze(protokoli 013 i 015) praćeni su do 4 godine medijan 3, 7 godina.
At end of study, individuals enrolled in the two Phase-III studies(Protocol- 013 and Protocol-015), were followed for up to 4 years median 3.7 years.

Oni koji slede put ispitivanja spoznaju da je um koji preostane na kraju ispitivanja- Brahman.
Those who follow the path of enquiry realize that the mind which remains at the end of the enquiry is Brahman.

Na kraju ispitivanja, 14(48,3%), 7(24,1%) i 5(17,2%) bolesnika postiglo je smanjenje parenteralne prehrane od 1 dana, 2 dana odnosno 3 dana tjedno.
At the end of study, 14(48.3%), 7(24.1%) and 5(17.2%) patients achieved a reduction of 1, 2, or 3 days per week in parenteral nutrition, respectively.

Djelotvornost cjepiva protiv cervikalnih lezija visokog stupnja, povezanih sa HPV-16/18, a koje su uočene u TVC na kraju ispitivanja, prikazana je u Tablici 3.
Vaccine efficacy against high grade cervical lesions associated with HPV-16/18 observed in TVC at end of study is presented in Table 3.

Na kraju ispitivanja, Kayla nam je iz vedra neba rekla da ima rođaka po imenu Brendan.
And just about at the end of that interview, Kayla, out of the blue, basically came out and told us that, uh, she had a cousin by the name of Brendan and that Brendan was, quote.

Bolesnici u skupini koja je primala lijek jednom tjedno osjetili su klinički značajnu srednju vrijednost poboljšanja od 15% u FEV1 na kraju ispitivanja.
The patients in the weekly treatment group experienced a clinically significant 15% mean improvement in FEV1 at the end of the study.

Na kraju ispitivanja učinak na srednju vrijednost tjelesne težine bio je neutralan(+0, 6 kg u skupini liječenoj vildagliptinom i-0, 1 kg u skupini liječenoj placebom).
At the end of the study, effect on mean body weight was neutral(+0.6kg in the vildagliptin group and -0.1 kg in the placebo group).

Djelotvornost cjepiva na virološke ishode(6-mjesečne i 12-mjesečne perzistentne infekcije) povezane sa HPV-16/18 uočene u TVC na kraju ispitivanja prikazana je u Tablici 4.
Vaccine efficacy against virological endpoints(6-month and 12-month persistent infection) associated with HPV-16/18 observed in TVC at end of study is presented in Table 4.

Predstavljajući svoje zaključke na kraju ispitivanja, EP je ustanovio da se borba protiv terorizma nikada ne može opravdati tajnim i nezakonitim masovnim nadzorom.
Presenting its findings at the end of the inquiry, Parliament stated that the fight against terrorism can never justify secret and illegal mass surveillance.

U skupini koja je primala enalapril, 75% bolesnika ostalo je na ciljnoj dozi od 10 mg dvaput na dan na kraju ispitivanja srednja dnevna doza od 18, 9 mg.
In the enalapril group, 75% of patients remained on the target dose of 10 mg twice daily at the end of the study mean daily dose of 18.9 mg.

Na kraju ispitivanja eksenatida s trenutnim oslobađanjem je(n=137) postignuto statistički značajno sniženje vrijednosti HbA1c i tjelesne težine u usporedbi s placebom n=122.
At the end of the study, immediate-release exenatide(n=137) demonstrated a statistically significant reduction in the HbA1c and weight compared to placebo n=122.

Glavna mjera djelotvornosti u oba ispitivanja bio je postotak bolesnika čiji su simptomi žgaravice potpuno povukli na kraju ispitivanja.
The main measure of effectiveness in both studies was the percentage of patients whose heartburn symptoms had completely cleared up at the end of the study.

Glavna mjera učinkovitosti bio je broj novih vertebralnih prijeloma na kraju ispitivanja, iako su se ispitivanjem također proučavali nevertebralni prijelomi.
The main measure of effectiveness was the number of new vertebral fractures at the end of the study, although the study also looked at non-vertebral fractures.

Djelotvornost cjepiva protiv viroloških ishoda(6-mjesečna i 12-mjesečna perzistentna infekcija) povezana sa HPV-16/18, uočena u ATP kohorti na kraju ispitivanja, prikazana je u Tablici 2.
Vaccine efficacy against virological endpoints(6-month and 12-month persistent infection) associated with HPV-16/18 observed in the ATP cohort at the end of study is presented in Table 2.

Podaci o djelotvornosti za relevantne ishode analizirani na kraju ispitivanja(medijan trajanja praćenja 2, 4 godine) u populaciji koja je završila ispitivanje u skladu s protokolom prikazani su u Tablici 5.
The efficacy results for relevant endpoints analysed at end of study(median duration of follow-up 2.4 years) in the per-protocol population are presented in the Table 5.

U 32 od 48 bolesnika(67%) s nastalom samom D168V supstitucijom i u 34 od 66(52%) bolesnika s nastalom samom R155K supstitucijom, dotične nastale varijante nisu više bile detektabilne na kraju ispitivanja.
In 32 out of 48 patients(67%) with emerging single D168V and in 34 out of 66(52%) patients with emerging single R155K, the respective emerging variants were no longer detected at end of the studies.

Sniženja razine glukoze u plazmi na kraju ispitivanja postignuta uz Toujeo bila su slična onima postignutima uz inzulin glargin jačine 100 jedinica/ml, ali je smanjenje tijekom razdoblja titracije bilo postupnije uz Toujeo.
Plasma glucose reductions at the end of the trial with Toujeo were similar to insulin glargine 100 units/ml with a more gradual reduction during the titration period with Toujeo.

Suboxone je bio jednako djelotvoran kao i monoterapija buprenorfinom, a djelotvorniji od placeba: 17, 8% bolesnika koji su primali lijek Suboxone imalo je negativan nalaz urina na kraju ispitivanja, u usporedbi s 5, 8% bolesnika koji su primali placebo.
Suboxone was as effective as buprenorphine on its own and more effective than placebo: 17.8% of the patients who received Suboxone had a urine sample that tested negative at the end of the study, compared with 5.8% of the patients receiving placebo.

Na kraju ispitivanja učinak na srednju vrijednost tjelesne težine bio je neutralan promjena od +0, 6 kg u odnosu na početnu vrijednost u skupini liječenoj vildagliptinom, dok u skupini liječenoj placebom nije bilo promjene težine.
At the end of the study, effect on mean body weight was neutral +0.6 kg change from baseline in the vildagliptin group and no weight change in the placebo group.